Shareholder Alert: Ademi LLP investigates whether 1Life Healthcare, Inc. has obtained a Fair Price in its transaction with Amazon
MILWAUKEE, July 21, 2022 /PRNewswire/ -- Ademi LLP is investigating One Medical (NASDAQ: ONEM) for possible breaches of fiduciary duty and other violations of law in its transaction with Amazon.
Click here to learn how to join the action: https://www.ademilaw.com/case/1life-healthcare-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
Ademi LLP alleges One Medical's financial outlook and prospects are excellent and yet One Medical holders will receive only $18 per share in an all-cash transaction valued at approximately $3.9 billion, including One Medical's net debt. The transaction agreement unreasonably limits competing bids for One Medical by imposing a significant penalty if One Medical accepts a superior bid. One Medical insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of One Medical's board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for One Medical.
If you own One Medical common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or https://www.ademilaw.com/case/1life-healthcare-inc.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
SOURCE Ademi LLP
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article